Weekend therapy in diabetes

Journal of the Pakistan Medical Association

Volumn 66, Issue 5, 2016, Pages 627-628

  Kalra, Sanjay ^a   Gupta, Yashdeep ^b  

^a India   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Dulaglutide; Exenatide QW; Glucagon like peptide 1 receptor agonists (GLP1RA); Omarigliptin; Semaglutide; Trelagliptin

Indexed keywords

ANTIDIABETIC AGENT;

BLOOD GLUCOSE MONITORING; DIABETES MELLITUS; DRUG ADMINISTRATION; HUMAN;

BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS; DRUG ADMINISTRATION SCHEDULE; HUMANS; HYPOGLYCEMIC AGENTS;

EID: 84963589452     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Iglay K, Cao X, Mavros P, Joshi K, Yu S, Tunceli K. Systematic Literature Review and Meta-analysis of Medication Adherence With Once-weekly Versus Once-daily Therapy. Clin therap, 2015; 37: 1813-1821.
2. Loesche C, Pernin C, Poncet M. Adapalene 0.1% and benzoyl peroxide 2.5% as a fixed-dose combination gel is as well tolerated as the individual components alone in terms of cumulative irritancy. Eur J Dermatol, 2008; 18: 524-526.
3. Burness C B. Omarigliptin: First Global Approval. Drugs, 2015;75: 1947-1952.
4. McKeage K. Trelagliptin: first global approval. Drugs, 2015; 75: 1161-1164.
5. MacConell L, Gurney K, Malloy J, Zhou M, Kolterman O. Safety and tolerability of exenatide once weekly in patients with type 2 diabetes: an integrated analysis of 4,328 patients. Diabetes Metab Syndr Obes. 2015; 8: 241-253.
6. Gurung T, Shyangdan DS, O'Hare JP, Waugh N. A novel, longacting glucagon-like peptide receptor-agonist: dulaglutide. Diabetes Metab Syndr Obes.2015; 8: 363-368.
7. Lau J, Bloch P, Schaffer L, Pettersson I, Spetzler J, Kofoed J, et al. Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide. J Med Chem 2015; 58: 7370-7380.
8. Kalra S, Gupta Y. DOT (directly observed therapy) in diabetes: Current thought, future reality. Aust J Rural Health. 2014; 22, 206-206.